
A common medicine used in the treatment of diabetes can reduce the risk of Alzheimer’s by almost a fifth, according to a new study.
Research published in the BMJ Open Diabetes Research & Care journal found that thiazolidinediones, commonly known as TZDs, can increase oxygen supply to the brain.